IQVIA Holdings (IQV) observed a variety of market occurrences based on the forecast data. The significant events included lowering of growth forecasts, return on equity posting impressive 23%, and trading analysis insights.
CFO, Ron Bruehlman, addressed the UBS Global Healthcare Conference in November 2024, and it announced Q4 and Full-year 2024 earnings call date for February 6th. The company also revealed their strategy for refinancing loans for reduced interest rates. Unfortunately, IQVIA shareholders suffered a loss of 29% in the last three years. The company underwent strengthened
momentum despite market challenges, with an impressive 2.5% earnings growth over a year but this didn't translate to positive returns for shareholders. IQVIA was lauded for using debt sensibly and won
2024 PM360 Innovation Award for Artificial Intelligence. Negative signs included
insider selling of IQVIA stock. Collaboration with NVIDIA for
advanced agentic AI solutions was a highlighted event. Furthermore, the annual earning beat estimates and Q4 revenue was reported at $3.96 B, against FactSet est of $3.93 B.
Iqvia Holdings IQV News Analytics from Thu, 02 May 2024 07:00:00 GMT to Sat, 22 Mar 2025 14:01:01 GMT -
Rating 2
- Innovation 5
- Information 8
- Rumor -2
